Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.